BCYCBICYCLE THERAPEUTICS PLCvs its industry peers
A metric-by-metric comparison of BICYCLE THERAPEUTICS PLC against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCYCThis | — | — | — | — | 105.8%#2 | -29.5%#3 | -340.4%#3 | -42.9%#3 | -794.1%#2 | — | — | — |
| VNDA | $306M#2 | — | 1.1x#1 | 1.4x#1 | 8.7%#3 | -1066.7%#5 | -70.0%#2 | -78.5%#4 | — | — | 19.7%#2 | — |
| LYEL | $303M#3 | — | 1.1x#2 | 8419.7x#4 | -41.0%#5 | 20.0%#2 | -748344.4%#5 | -100.3%#5 | — | — | — | — |
| OVID | $411M#1 | — | 2.1x#3 | 56.6x#3 | 1181.3%#1 | 34.1%#1 | -585.2%#4 | -8.8%#1 | — | — | 340.0%#1 | — |
| RMTI | $283M#4 | — | 7.9x#4 | 4.1x#2 | -31.8%#4 | -1007.1%#4 | -6.8%#1 | -14.8%#2 | -13.3%#1 | 3#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-08-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice